Concepedia

Publication | Open Access

Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis

DOIFull Paper Access

64

Citations

26

References

2016

Year

William J. Sandborn, Bal Raj Bhandari, Ronald Fogel, Jane E. Onken, Eugene F. Yen, Xin Zhao, Zhaoshi Jiang, Dongliang Ge, Z. Ye, Dorothy French,
Alimentary Pharmacology & Therapeutics

Abstract

This phase 1 trial provides preliminary evidence for the safety and therapeutic potential of GS-5745 in the treatment of ulcerative colitis.

References

YearCitations

Page 1